pharma news

News

Indivior has agreed to halt all marketing of its opioid overdose drug Opvee in New York after being rapped for mispromoting it to health officials.

News

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

News

Novartis has claimed a first-in-class approval in the US for its oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria.

News

The US government has shut down after Republicans and Democrats failed to resolve a budget standoff and the federal government ran out of money.

News

At the White House today, President Trump and Pfizer CEO Albert Bourla announced the first of many deals to secure MFN drug prices for US consumers.

News

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.